Xueyuan Chen
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Comparative efficacy and safety of post-TKI treatments for advanced EGFR-mutant non-small-cell lung cancer: a systematic review and network meta-analysis.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 23, 2025
Skeletal Muscle Metastasis in Patients With SMARCA4-Deficient Thoracic Tumors: A Retrospective Cohort Study.
Journal: International journal of cancer
Published: September 26, 2025
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer.
Journal: Cancer cell
Published: August 01, 2025
Genomic biomarkers of immunotherapy plus chemotherapy in patients with advanced NSCLC: Insights from the phase 3 ORIENT-11 study.
Journal: iScience
Published: March 18, 2025
Efficacy of antiangiogenic therapy in patients with advanced SMARCA4-deficient thoracic tumor.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 06, 2025
SMARCA4 deficient undifferentiated tumor in nasopharynx.
Journal: Oral oncology
Published: December 12, 2024
A Novel Inflammation-Marker-Based Prognostic Model for Advanced Pulmonary Lymphoepithelioma-Like Carcinoma.
Journal: Journal of inflammation research
Published: November 04, 2024
Molecular subtypes and prognostic factors of lung large cell neuroendocrine carcinoma.
Journal: Translational lung cancer research
Published: April 04, 2024
The maximum tumor growth rate predicts clinical outcomes of patients with small-cell lung cancer undergoing first-line chemotherapy plus immune-checkpoint inhibitor therapy.
Journal: Cancer medicine
Published: September 21, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026